Mount Sinai Journal of Medicine A Journal of Translational and Personalized Medicine · 2011 · 136 citations · 115 references
Life SciencesNeurologyNeuroscienceNeurodegenerationNeuroimmunologyNeuropathologyAxonal DegenerationDemyelinating DiseasesDemyelinating DisordersMultiple SclerosisNeurodegenerative DiseasesNeuroinflammationDemyelination PathophysiologyImmune-mediated DemyelinationImmune-mediated PathogenesisImmunomodulatory EffectsMultiple Sclerosis ImmunopathogenesisMultiple Sclerosis ImmunopathologyMultiple Sclerosis TherapyNeuroinflammation In Multiple Sclerosis
Multiple sclerosis is a debilitating disease of the central nervous system that has been characteristically classified as an immune-mediated destruction of myelin, the protective coating on nerve fibers. Although the mechanisms responsible for the immune attack to central nervous system myelin have been the subject of intense investigation, more recent studies have focused on the neurodegenerative component, which is cause of clinical disability in young adults and appears to be only partially controlled by immunomodulatory therapies. Here, we review distinct, but not mutually exclusive, mechanisms of pathogenesis of axonal damage in multiple sclerosis patients that are either consequent to long-term demyelination or independent from it. We propose that the complexity of axonal degeneration and the heterogeneity of the underlying pathogenetic mechanisms should be taken into consideration for the design of targeted therapeutic intervention.
115
Axonal Transection in the Lesions of Multiple Sclerosis
Bruce D. Trapp, John W. Peterson, Richard M. Ransohoff et al. · New England Journal of Medicine · 1998 · 4K citations · Full text
Axonal damage in acute multiple sclerosis lesions
Betsy Ferguson · Brain · 1997 · 1.5K citations · Full text
The relation between inflammation and neurodegeneration in multiple sclerosis brains
Josa M. Frischer, Stephan Bramow, Assunta Dal‐Bianco et al. · Brain · 2009 · 1.4K citations · Full text